Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rayyan R. Zafar"'
Autor:
Anne Katrin Schlag, Rayyan R. Zafar, Michael T. Lynskey, Alkyoni Athanasiou-Fragkouli, Lawrence D. Phillips, David J. Nutt
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Randomised controlled trials (RCTs) have long been considered the gold standard of medical evidence. In relation to cannabis based medicinal products (CBMPs), this focus on RCTs has led to very restrictive guidelines in the UK, which are limiting pat
Externí odkaz:
https://doaj.org/article/d93d9487f8ec4e48a9663b5332fb97db
Autor:
Wall MB; Invicro, London, UK.; Faculty of Medicine, Imperial College London, London UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Harding R; Clinical Psychopharmacology Unit, Faculty of Brain Sciences, University College London, UK., Ertl N; Invicro, London, UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Barba T; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Zafar R; Faculty of Medicine, Imperial College London, London UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Sweeney M; Faculty of Medicine, Imperial College London, London UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Nutt DJ; Faculty of Medicine, Imperial College London, London UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK., Rabiner EA; Invicro, London, UK., Erritzoe D; Faculty of Medicine, Imperial College London, London UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, UK.
Publikováno v:
Neuroscience insights [Neurosci Insights] 2024 Oct 08; Vol. 19, pp. 26331055241286518. Date of Electronic Publication: 2024 Oct 08 (Print Publication: 2024).
Autor:
Wall MB; Invicro, London, UK. matthew.wall@imperial.ac.uk.; Faculty of Medicine, Imperial College London, London, UK. matthew.wall@imperial.ac.uk.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK. matthew.wall@imperial.ac.uk., Harding R; Clinical Psychopharmacology Unit, Faculty of Brain Sciences, University College London, London, UK., Zafar R; Faculty of Medicine, Imperial College London, London, UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK., Rabiner EA; Invicro, London, UK., Nutt DJ; Faculty of Medicine, Imperial College London, London, UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK., Erritzoe D; Faculty of Medicine, Imperial College London, London, UK.; Centre for Psychedelic research and Neuropsychopharmacology, Imperial College London, London, UK.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2023 Sep; Vol. 28 (9), pp. 3573-3580. Date of Electronic Publication: 2023 Sep 27.
Autor:
Abrams SK; Numinus Toronto, Toronto, Ontario, Canada., Rabinovitch BS; Numinus Toronto, Toronto, Ontario, Canada.; Division of Fundamental Neurobiology, Krembil Research Institute, Toronto, Ontario, Canada.; Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Zafar R; Centre for Psychedelic Research and Neuropsychopharmacology, Imperial College, London, United Kingdom., Aziz AS; Pediatric Neurology Clinic, Oakville, Ontario, Canada., Cherup NP; The Miami Project to Cure Paralysis, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA.; Department of Neurological Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA., McMillan DW; The Miami Project to Cure Paralysis, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA.; Department of Neurological Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA., Nielson JL; Department of Psychiatry and Behavioral Sciences; Institute for Health Informatics, University of Minnesota, Minneapolis, Minnesota, USA., Lewis EC; Numinus Toronto, Toronto, Ontario, Canada.; Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
Neurotrauma reports [Neurotrauma Rep] 2023 Aug 22; Vol. 4 (1), pp. 543-550. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).
Autor:
Zafar R; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Siegel M; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Harding R; Clinical Psychopharmacology Unit, University College London, London, United Kingdom., Barba T; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Agnorelli C; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Suseelan S; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Roseman L; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Wall M; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Invicro, London, United Kingdom., Nutt DJ; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Erritzoe D; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.; Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
Publikováno v:
Frontiers in psychiatry [Front Psychiatry] 2023 Jun 12; Vol. 14, pp. 1183740. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Autor:
Nutt D; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Hayes A; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Fonville L; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Zafar R; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Palmer EOC; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Paterson L; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK., Lingford-Hughes A; Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Hammersmith Hospital, Imperial College London, London W12 ONN, UK.
Publikováno v:
Nutrients [Nutrients] 2021 Nov 04; Vol. 13 (11). Date of Electronic Publication: 2021 Nov 04.
Autor:
Schlag AK; Drug Science, St Peter's House, London, UK.; Neuropsychopharmacology Unit, Centre for Psychiatry, Imperial College London, London, UK., Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK.; University College Hospital National Institute of Health Research (NIHR) Biomedical Research Centre, London, UK., Zafar R; Drug Science, St Peter's House, London, UK.; Neuropsychopharmacology Unit, Centre for Psychiatry, Imperial College London, London, UK., Nutt DJ; Drug Science, St Peter's House, London, UK.; Neuropsychopharmacology Unit, Centre for Psychiatry, Imperial College London, London, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK.; University College Hospital National Institute of Health Research (NIHR) Biomedical Research Centre, London, UK.
Publikováno v:
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2021 Jul; Vol. 35 (7), pp. 773-785. Date of Electronic Publication: 2021 Feb 17.
Autor:
Blackman G, Lisshammar JEL, Zafar R; Centre for Neuropsychopharmacology, Imperial College London Trust., Pollak TA, Pritchard M; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London., Cullen AE; From the Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London., Rogers J, Carter B; Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London., Griffiths K; From the Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London., Nour M, David AS, McGuire P, Stewart R, MacCabe J
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2021 Jan/Feb 01; Vol. 41 (1), pp. 19-24.